检索结果 - Isamu Okamoto

Refine Results
  1. 1
    Epidermal growth factor receptor in relation to tumor development: EGFR‐targeted anticancer therapy

    Epidermal growth factor receptor in relation to tumor development: EGFR‐targeted anticancer therapy 由 Isamu Okamoto

    出版 2009
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    MET-targeted therapy for gastric cancer: the importance of a biomarker-based strategy

    MET-targeted therapy for gastric cancer: the importance of a biomarker-based strategy 由 Hisato Kawakami, Isamu Okamoto

    出版 2015
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  3. 3
    Clinical Impact of Continued Crizotinib Administration after Isolated Central Nervous System Progression in Patients with Lung Cancer Positive for ALK Rearrangement

    Clinical Impact of Continued Crizotinib Administration after Isolated Central Nervous System Progression in Patients with Lung Cancer Positive for ALK Rearrangement 由 Masayuki Takeda, Isamu Okamoto, Kazuhiko Nakagawa

    出版 2013
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Rapid Response of Brain Metastasis to Crizotinib in a Patient with ALK Rearrangement–Positive Non–Small-Cell Lung Cancer

    Rapid Response of Brain Metastasis to Crizotinib in a Patient with ALK Rearrangement–Positive Non–Small-Cell Lung Cancer 由 Hiroyasu Kaneda, Isamu Okamoto, Kazuhiko Nakagawa

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Survival Outcome Assessed According to Tumor Response and Shrinkage Pattern in Patients with EGFR Mutation–Positive Non–Small-Cell Lung Cancer Treated with Gefitinib or Erlotinib

    Survival Outcome Assessed According to Tumor Response and Shrinkage Pattern in Patients with EGFR Mutation–Positive Non–Small-Cell Lung Cancer Treated with Gefitinib or Erlotinib... 由 Masayuki Takeda, Isamu Okamoto, Kazuhiko Nakagawa

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Differential roles of trans-phosphorylated EGFR, HER2, HER3, and RET as heterodimerisation partners of MET in lung cancer with MET amplification

    Differential roles of trans-phosphorylated EGFR, HER2, HER3, and RET as heterodimerisation partners of MET in lung cancer with MET amplification 由 Junko Tanizaki, Isamu Okamoto, Kazuko Sakai, Kazuhiko Nakagawa

    出版 2011
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Postprogression survival for first-line chemotherapy of patients with advanced non-small-cell lung cancer

    Postprogression survival for first-line chemotherapy of patients with advanced non-small-cell lung cancer 由 Hidetoshi Hayashi, Isamu Okamoto, Satoshi Morita, Masataka Taguri, Kazuhiko Nakagawa

    出版 2011
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  8. 8
    Human Ect2 Is an Exchange Factor for Rho Gtpases, Phosphorylated in G2/M Phases, and Involved in Cytokinesis

    Human Ect2 Is an Exchange Factor for Rho Gtpases, Phosphorylated in G2/M Phases, and Involved in Cytokinesis 由 Takashi Tatsumoto, Xiaozhen Xie, Rayah Blumenthal, Isamu Okamoto, Toru Miki

    出版 1999
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Role of ERK-BIM and STAT3-Survivin Signaling Pathways in ALK Inhibitor–Induced Apoptosis in EML4-ALK–Positive Lung Cancer

    Role of ERK-BIM and STAT3-Survivin Signaling Pathways in ALK Inhibitor–Induced Apoptosis in EML4-ALK–Positive Lung Cancer 由 Ken Takezawa, Isamu Okamoto, Kazuto Nishio, Pasi A. Jänne, Kazuhiko Nakagawa

    出版 2011
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Severe Acute Interstitial Lung Disease After Crizotinib Therapy in a Patient With <i>EML4-ALK</i>–Positive Non–Small-Cell Lung Cancer

    Severe Acute Interstitial Lung Disease After Crizotinib Therapy in a Patient With <i>EML4-ALK</i>–Positive Non–Small-Cell Lung Cancer 由 Akihiro Tamiya, Isamu Okamoto, Masaki Miyazaki, Shigeki Shimizu, Masanori Kitaichi, Kazuhiko Nakagawa

    出版 2012
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    EGFR mutation in gefitinib-responsive small-cell lung cancer

    EGFR mutation in gefitinib-responsive small-cell lung cancer 由 Isamu Okamoto, Jun Araki, Ryuichiro Suto, Mitsuo Shimada, Kazuhiko Nakagawa, M. Fukuoka

    出版 2005
    获取全文 获取全文
    Carta
    加到收藏夹
    Saved in:
  12. 12
    Targeting MET Amplification as a New Oncogenic Driver

    Targeting MET Amplification as a New Oncogenic Driver 由 Hisato Kawakami, Isamu Okamoto, Wataru Okamoto, Junko Tanizaki, Kazuhiko Nakagawa, Kazuto Nishio

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    MET Tyrosine Kinase Inhibitor Crizotinib (PF-02341066) Shows Differential Antitumor Effects in Non-small Cell Lung Cancer According to MET Alterations

    MET Tyrosine Kinase Inhibitor Crizotinib (PF-02341066) Shows Differential Antitumor Effects in Non-small Cell Lung Cancer According to MET Alterations 由 Junko Tanizaki, Isamu Okamoto, Kunio Okamoto, Ken Takezawa, Kiyoko Kuwata, Haruka Yamaguchi, Kazuhiko Nakagawa

    出版 2011
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    Regulated CD44 Cleavage under the Control of Protein Kinase C, Calcium Influx, and the Rho Family of Small G Proteins

    Regulated CD44 Cleavage under the Control of Protein Kinase C, Calcium Influx, and the Rho Family of Small G Proteins 由 Isamu Okamoto, Yoshiaki Kawano, Mitsuhiro Matsumoto, Moritaka Suga, Kozo Kaibuchi, Masayuki Ando, Hideyuki Saya

    出版 1999
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    TP53 gain-of-function mutations promote osimertinib resistance via TNF-α–NF-κB signaling in EGFR-mutated lung cancer

    TP53 gain-of-function mutations promote osimertinib resistance via TNF-α–NF-κB signaling in EGFR-mutated lung cancer 由 Ritsu Ibusuki, Eiji Iwama, Atsushi Shimauchi, Hirono Tsutsumi, Yasuto Yoneshima, Kentaro Tanaka, Isamu Okamoto

    出版 2024
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    Remarkable response to crizotinib in a patient with advanced lung adenocarcinoma harboring the MPRIP-ROS1 fusion gene: A case report

    Remarkable response to crizotinib in a patient with advanced lung adenocarcinoma harboring the MPRIP-ROS1 fusion gene: A case report 由 Yasuyuki Kishikawa, Kohei Otsubo, Daisuke Shibahara, Yoshimasa Shiraishi, Yasuto Yoneshima, Eiji Iwama, Isamu Okamoto

    出版 2025
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    De Novo Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in EGFR Mutation-Positive Patients with Non-small Cell Lung Cancer

    De Novo Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in EGFR Mutation-Positive Patients with Non-small Cell Lung Cancer 由 Masayuki Takeda, Isamu Okamoto, Yoshihiko Fujita, Tokuzo Arao, Hiroyuki Ito, Masahiro Fukuoka, Kazuto Nishio, Kazuhiko Nakagawa

    出版 2010
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    Enhanced Anticancer Effect of the Combination of BIBW2992 and Thymidylate Synthase–Targeted Agents in Non–Small Cell Lung Cancer with the T790M Mutation of Epidermal Growth Factor Receptor

    Enhanced Anticancer Effect of the Combination of BIBW2992 and Thymidylate Synthase–Targeted Agents in Non–Small Cell Lung Cancer with the T790M Mutation of Epidermal Growth Factor... 由 Ken Takezawa, Isamu Okamoto, Junko Tanizaki, Kiyoko Kuwata, Haruka Yamaguchi, Masahiro Fukuoka, Kazuto Nishio, Kazuhiko Nakagawa

    出版 2010
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    Inhibition of Insulin-Like Growth Factor 1 Receptor by CP-751,871 Radiosensitizes Non–Small Cell Lung Cancer Cells

    Inhibition of Insulin-Like Growth Factor 1 Receptor by CP-751,871 Radiosensitizes Non–Small Cell Lung Cancer Cells 由 Tsutomu Iwasa, Isamu Okamoto, Minoru Suzuki, Erina Hatashita, Yuki Yamada, Masahiro Fukuoka, Koji Ono, Kazuhiko Nakagawa

    出版 2009
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    Phase I Clinical and Pharmacokinetic Study of RAD001 (Everolimus) Administered Daily to Japanese Patients with Advanced Solid Tumors

    Phase I Clinical and Pharmacokinetic Study of RAD001 (Everolimus) Administered Daily to Japanese Patients with Advanced Solid Tumors 由 Isamu Okamoto, Toshihiko Doi, Atsushi Ohtsu, Masaki Miyazaki, Asuka Tsuya, K. Kurei, Kazuma Kobayashi, K. Nakagawa

    出版 2009
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: